Destination
Wegovy and Ozempic top list of 15 drugs up for next price negotiations

If the Trump admin doesn't alter the process, negotiated prices will go into effect in 2027. [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
Windscribe review: Despite the annoyances, it has the right idea

Windscribe is a virtual private network (VPN) with intense "How do you do, fellow kids?" energy. It has servers in 69 countries and an annual plan that costs $69, an obsession with the sex n [...]

Match Score: 102.53

Destination
CyberGhost VPN review: Despite its flaws, the value is hard to beat

CyberGhost is the middle child of the Kape Technologies VPN portfolio, but in quality, it's much closer to ExpressVPN than Private Internet Access. I mainly put it on my best VPN list because it& [...]

Match Score: 99.66

Destination
Private Internet Access VPN review: Both more and less than a budget VPN

I came into this review thinking of Private Internet Access (PIA) as one of the better VPNs. It's in the Kape Technologies portfolio, along with the top-tier ExpressVPN and the generally reliable [...]

Match Score: 99.39

thenextweb
Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Match Score: 95.88

Destination
Mullvad VPN review: Near-total privacy with a few sacrifices

Mullvad, a virtual private network (VPN) named after the Swedish word for "mole," is often recognized as one of the best VPNs for privacy. I put it on my best VPN list for exactly that reaso [...]

Match Score: 92.20

Destination
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical tr [...]

Match Score: 83.40

Destination
Norton VPN review: A VPN that fails to meet Norton's standards

One thing I need to make clear right from the start: this is a review of Norton VPN (formerly Norton Secure VPN, and briefly Norton Ultra VPN) as a standalone app, not of the VPN feature in the Norton [...]

Match Score: 79.85

Destination
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]

Match Score: 74.55

Destination
Proton VPN review 2025: A nonprofit service with premium performance

Proton VPN stands out for two main reasons: it's one of the only virtual private networks (VPNs) to include a free plan with no data limits, and it's one of the few services majority-owned b [...]

Match Score: 60.18